SCHEMBL9360679

SCHEMBL9360679

Cc1ccc(OC(=O)/C=C\C(N)=O)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.53
DDAH1 O94760 1/20 0.51
PRSS1 P07477 1/20 0.45
ACR P10323 1/20 0.45
ALDH1A1 P00352 3/20 0.43
KMT2A Q03164 5/20 0.42
GAA P10253 1/20 0.41
PKM P14618 2/20 0.41
HTT P42858 2/20 0.41
ATM Q13315 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
HPGD P15428 1/20 0.41
NLRP1 Q9C000 1/20 0.41
MEN1 O00255 1/20 0.41
NTSR1 P30989 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MAPT P10636 1/20 0.41
USP2 O75604 1/20 0.41
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8166082 0.90 LMNA (0.64) LMNAPRSS1ACRALDH1A1KMT2A
SCHEMBL8998922 0.90 LMNA (0.64) LMNAPRSS1ACRALDH1A1KMT2A
SCHEMBL8998925 0.90 LMNA (0.64) LMNAPRSS1ACRALDH1A1KMT2A
SCHEMBL1485799 0.85 PARP10 (0.52) LMNAPRSS1ACRKMT2AATM
SCHEMBL17695796 0.82 LMNA (0.55) LMNAALDH1A1KMT2AGAAPKM
SCHEMBL2221244 0.82 PARP10 (0.46) LMNAPRSS1ALDH1A1KMT2AGAA
SCHEMBL27416289 0.82 LMNA (0.55) LMNAPRSS1ACRALDH1A1KMT2A
SCHEMBL7459980 0.82 PARP10 (0.46) ALDH1A1KMT2AGAAMEN1TDP1
SCHEMBL28894207 0.82 LMNA (0.55) LMNAALDH1A1KMT2AGAAPKM
SCHEMBL27657141 0.82 LMNA (0.55) LMNAPRSS1ACRALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160297828-A1 SPIROCYCLIC COMPOUNDS CONTAINING SPIRO[INDOLYL-3,1'-PYRROLO[3,4-C]PYRROLE] CORE AND SULPHUR-CONTAINING AMINO ACID RESIDUES ZAGORII GLEB VLADIMIROVICH (UA) 2016-10-13 US disclosed
EP-0393713-B1 Process for the preparation of N-substituted maleimides TOSOH CORP (JP) 1994-06-29 EP disclosed
US-5087705-A Heating N-substituted maleamic acid monoester in presence of acid catalyst SHIN-DAIKYOWA PETROCHEMICAL CO., LTD. (JP) 1992-02-11 US disclosed
EP-0393713-A1 Process for the preparation of N-substituted maleimides Tosoh Corporation (JP) 1990-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160297828-A1 SPIROCYCLIC COMPOUNDS CONTAINING SPIRO[INDOLYL-3,1'-PYRROLO[3,4-C]PYRROLE] CORE AND SULPHUR-CONTAINING AMINO ACID RESIDUES CRHR1, NR3C1, MC2R LMNA 3563/4885DDAH1 1376/4885PRSS1 404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.